At-home telemedicine controlled taVNS twice daily for 4 weeks reduces long COVID symptoms of anxiety and fatigue
Guardado en:
Autores principales: | Christopher Austelle, Bashar Badran, Sarah Huffman, Morgan Dancy, Steven Kautz, Mark George |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bdaabdfe16c64844af18c32008c2d7ac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.
por: Sarah Huffman, et al.
Publicado: (2021) -
Increasing the number of daily stimulation sessions administered during taVNS-paired bottle feeding speeds response time in newborns with feeding difficulty
por: Lauren Adams, et al.
Publicado: (2021) -
Parametric modulation of the heart and brain using transcutaneous auricular vagus nerve stimulation (taVNS)
por: Bashar Badran
Publicado: (2021) -
Predicting response to transcutaneous auricular vagus nerve stimulation (taVNS) paired with oromotor feeding in neonates: CNS metabolite biomarkers by MR spectroscopy (MRS)
por: Sally Hunt, et al.
Publicado: (2021) -
Diffusional kurtosis imaging reveals taVNS facilitates microstructural changes in the developing neonatal brain
por: Hunter Moss, et al.
Publicado: (2021)